SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: Rocketman who wrote (5845)10/30/1998 2:09:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 9719
 
Rman:

>> This is thought by some to be what killed Centorcor and Sepragen's clinicals on Sepsis <<

The Centocor phase III trial was halted because recipients of HA-1A were dying at a higher frequency than recipients of placebo.

Sepragen....... I think you might have meant Synergen?

Happy hauntings!

Rick



To: Rocketman who wrote (5845)10/30/1998 3:17:00 PM
From: Bluegreen  Respond to of 9719
 
Rman, why not put your old INCY hat on and take Jack to lunch. He would probably still remember you from that annual meeting. I have always enjoyed your posts and the report you gave of Xoma that year you attended. Now if I could just get you away from Dr. Harmon's mesmerizing pocket watch!<g>